Immunological tolerance to thymus-independent (TI) antigens can be readily induced by the injection of supraimmunogenic doses of the antigens. Although tolerance to certain TI antigens, such as lipopolysaccharide (LPS) can be reversed by transferring tolerant cells to irradiated animals or by simply incubating the cells in culture in the absence of antigen (1), other TI antigens like dextrans and levans induce a stable nonreversible state of specific tolerance (2) . Tolerance to TI antigens like dextran represents a direct effect on the antigenspecific B cells and the participation of suppressor cells has been excluded (3) . It has been suggested that B lymphocytes are tolerized when the Ig receptors bind the antigen (signal 1) in the absence of a second signal (4) . Here we will show that specific immunological tolerance only affects a particular subset of B lymphocytes, whereas other B cells having the same immunological specificity are neither activated nor tolerized by interacting with the antigen. The variable that determines whether B cells become tolerant to a particular TI antigen is their susceptibility to the polyclonal B-cell-activating property of the antigen.
Results
The TI antigen used was fluorescein isothiocyanate-dextran B512 (FITCdextran), which was manufactured by Pharmacia Fine Chemicals, Uppsala, Sweden. Three preparations with different mol wt (150,000, 500,000, and l0 T the latter being native dextran) were tested. They all contained 1 FITC per 200 glucose residues. Mice were rendered tolerant to FITC-dextran by the intraperitoneal injection of 10 mg (with native FITC-dextran) or 100 mg of the antigen (with the other preparations). At 4-to 10 days after tolerance induction the spleens were removed and the number of anti-FITC plaque-forming cells (PFC) was determined by the Jerne and Nordin plaque assay (5) . Untreated mice or mice immunized with 100/~g of FITC-dextran served as controls. As can be seen in Fig. 1 , (an experiment with native FITC-dextran) tolerance induction resulted in a complete loss of anti-FITC PFC. The spleen cells from these mice were cultivated in vitro with no additions for 24 h in serum-free cultures, ii iii Fig. 1 were cultivated for 24 h in serum-free medium, harvested, and recultivated in 5% human A serum by using 3 x 105 cells/ml in 2 ml in 35-mm diameter Petri dishes in the presence of the indicated polyclonal B-cell activators. The following PBA concentrations were used: LPS 100 pg/ml, PPD 100 ~g/ml, and native dextran (Dex) 10 mg/ml. The cells were harvested on day 3 and tested against FITC as described in Fig. 1 (7), the interaction between the antigen and the antigen-binding Ig receptors cannot by itself cause a tolerance signal. Since only the B cells that could respond to the polyclonalactivating property of the antigen were made tolerant, it follows that the polyclonal B-cell-activating (PBA) property of the antigen is responsible for tolerance induction.
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FIG. 2. Cells from the animals in
These findings have far reaching implications for our understanding of signal delivery in lymphocyte activation and tolerance. They are clearly incompatible with the two signal concept stating that signal 1, which occurs ai~r binding of the antigen to the Ig receptors, results in tolerance induction, whereas signal one plus a second signal which can be delivered by e.g. collaborating T cells or by PBA properties of TI antigen, cause lymphocyte activation. Our experiments show that signal one by itself neither can activate nor tolerize antigen-specific B cells (Fig. 4) . Both activation and induction of specific tolerance necessarily required that the B cells possessed receptors for the polyclonal B-cell-activating properties of the TI antigen used as carrier. These findings are only compatible with the one nonspecific signal hypothesis of lymphocyte activation, which states that the activating signal is delivered only by polyclonal B-cell-activating properties of the TI antigen and that the Ig receptors do not signal any event in the B cells, but serve as passive focussing devices that allow the antigen to be focussed selectively to the antigen-specific cells. The selective induction of tolerance in those B cells that respond to the polyclonal B-cell activating properties of the antigen cannot be accommodated by any theory of lymphocyte activation that ascribes a signalling event by the interaction between the antigen and the Ig receptors. Summary Mice were rendered specifically tolerant to the fluorescein isothiocyanatedextran (FITC) epitope by injection of FITC-dextran B512. Their spleen cells were removed at various times and cultivated in vitro with different polyclonal B-cell activators, such as lipopolysaccharide (LPS), purified protein derivative of tuberculin, and native dextran. LPS caused the appearance of high affinity anti-FITC plaque-forming cells to an equal extent with cells from untreated and tolerant animals, whereas native dextran failed to activate cells from tolerant mice, although it was a potent activator of normal cells. It was concluded that tolerance induction only affects those B cells that could respond to the polyclonal B-cell-activating properties of the tolerogen, but not other B cells having an identical set of Ig receptors directed against the tolerogen.
